[Lecithin-cholesterol-acyltransferase activity in chronic liver diseases].
Activity of lecithin-cholesterol-acyl transferase (LCAT) was distinctly decreased in chronic impairments of liver tissue, especially under conditions of liver cirrhosis and hepatocellular cancer. After treatment with "essentiale forte" the enzymatic activity was elevated only in the patients with chronic hepatitis. The LCAT activity correlated with content of albumins, gamma-globulins and the data of thymol test. Estimation of the LCAT activity might serve as a diagnostic test in chronic liver tissue diseases.
Gaskina
T K
TK
Dolgov
A V
AV
Kurilovich
S A
SA
D000328:Adult; D002908:Chronic Disease; D004796:Clinical Enzyme Tests; D005260:Female; D006521:Hepatitis, Chronic / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D008103:Liver Cirrhosis / Q000175:diagnosis / Q000188:drug therapy; D008107:Liver Diseases / Q000175:diagnosis* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D007862:Phosphatidylcholine-Sterol O-Acyltransferase / Q000097:blood*; D010713:Phosphatidylcholines / Q000627:therapeutic use
D010713:Phosphatidylcholines; C011246:essential 303 forte; D007862:Phosphatidylcholine-Sterol O-Acyltransferase
Aktivnost' letsitin-kholesterol-atsiltransferasy pri khronicheskikh zabolevaniiakh pecheni.